KIF2C expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 3.00580005330175E-09 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.00429999999141E-05 |
Normal-vs-Stage2 |
6.420000E-03 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
1.011920E-02 |
Stage1-vs-Stage2 |
3.785200E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
2.137200E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
6.346000E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
9.17550000423262E-08 |
Normal-vs-AfricanAmerican |
3.590000E-02 |
Normal-vs-Asian |
1.733560E-01 |
Caucasian-vs-AfricanAmerican |
8.412200E-01 |
Caucasian-vs-Asian |
9.945200E-01 |
AfricanAmerican-vs-Asian |
8.641600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.840250E-04 |
Normal-vs-Female |
4.61529999995491E-06 |
Male-vs-Female |
3.965600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
3.815400E-03 |
Normal-vs-Extreme_Weight |
2.05689999999148E-05 |
Normal-vs-Obese |
7.177900E-03 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
6.041800E-01 |
Normal_Weight-vs-Obese |
1.558180E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
1.697410E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
6.790300E-02 |
Normal-vs-Age(41-60Yrs) |
1.682670E-03 |
Normal-vs-Age(61-80Yrs) |
2.08189999999497E-05 |
Normal-vs-Age(81-100Yrs) |
2.585800E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.603200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.705800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.795800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.932000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.947400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.516400E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
3.200800E-01 |
Normal-vs-Grade 3 |
8.020000E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
2.792800E-01 |
Grade 2-vs-Grade 4 |
3.200800E-01 |
Grade 3-vs-Grade 4 |
8.020000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.62500000011612E-07 |
Normal-vs-N1 |
3.028400E-02 |
N0-vs-N1 |
6.740400E-01 |
|
|